Metapharmaceutical Industrial

Meta Pharmaceutical Industrial is an AI-driven biotechnology company focused on the discovery and development of first-in-class small molecule drugs for autoimmune and metabolic diseases. The company leverages a proprietary platform that integrates structural biology, computational chemistry, and machine learning to accelerate the drug discovery process. Their lead programs target nutrient transporters and metabolic pathways, such as LAT1, to modulate immune responses. Headquartered in Shenzhen, China, Meta Pharmaceutical aims to address significant unmet medical needs through precision medicine and innovative chemical scaffolds. The company was incubated by XtalPi and is supported by leading venture capital firms.